uMotif to Showcase eConsent and eCOA Platform at Life Sciences Conferences
News related to:uMotif · 2 min read
uMotif, a fast-growing player in clinical trial technology, is set to showcase its modern eConsent and eCOA platform at a series of prominent life sciences conferences this fall, aiming to enhance patient and site relationships in clinical trials.
The company, which recently named Andrea Valente as its CEO, will present insights and best practices for leveraging consumer-grade technology to support participants and their connections to research sites. This initiative is part of uMotif’s ongoing commitment to putting the patient first, as demonstrated by its recent appointments and launches.
At the forefront of these upcoming events are:
- The SCDM 2026 Annual Conference in Raleigh, North Carolina, from September 14-17. - DPHARM in Boston, Massachusetts, from September 15-16. - OCT Southern California in San Diego, California, from September 15-16.
uMotif’s growing influence in the industry is evident through its recent milestones. In the first half of 2026, the company named Andrea Valente to the role of CEO, bringing extensive experience in operations to the helm. Additionally, the appointment of James Thatcher as Chief Commercial Officer adds a seasoned executive with a proven track record in sales. Florence Mowlem, PhD, was also named Chief Scientific Officer, and she recently received the 2026 PCMG Outsourcing Trailblazer of the Year Award.
The uMotif platform is designed to deliver high-quality, rapid clinical trials by placing patients at the center of research. It combines eConsent management, site productivity tools, and trial awareness to strengthen the patient-site relationship, critical for enhancing eCOA compliance and retention. The platform is GCP, 21 CFR Part 11, and GDPR compliant and supports all study phases and indications. With cloud hosting in the US, Europe, and China, uMotif ensures flexibility and accessibility for a wide range of clinical trials.
As uMotif prepares to participate in a series of conferences, the company remains focused on advancing its mission to improve patient engagement and streamline clinical trials. Attendees at these events can expect to learn more about uMotif’s innovative solutions and how they can contribute to smarter and faster clinical trials.